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Abstract  
Aim: Low Anterior Resection Syndrome (LARS) following rectal cancer surgery impairs the patient’s 
quality of life (QoL). Rectal Irrigation has been demonstrated to be effective for anterior resection 
syndrome but many surgeons do not suggest it as a treatment. This feasibility study aimed to explore 
treatment acceptability and the benefit of rectal irrigation in patients who developed LARS following 
an anterior resection for rectal cancer.  
Methods: This was a qualitative study, involving semi-structured interviews. Twenty-one patients 
diagnosed with LARS following anterior resection for rectal cancer in a single tertiary centre were 
offered rectal irrigation as a treatment option. Qualitative interviews (n=17) were conducted at 
baseline to explore patient reported impact of LARS on QoL, treatment acceptability and factors 
influencing the decision to accept/decline treatment. Follow up interviews were carried out at six 
months for the treatment group only (n=12), to assess its practicality and impact on QoL.  
 
Results: Qualitative interview findings suggest rectal irrigation is an acceptable method of treatment 
for LARS. Participants who perceived their symptoms to be more severe or poorly controlled were 
most likely to consider rectal irrigation as a treatment option. The patients who completed treatment 
reported improvements in their QoL, the ability to control the time of defaecation being the key 
benefit.  
Conclusion: Clinicians should consider offering rectal irrigation as a treatment option to patients 
presenting with bowel dysfunction following anterior resection as it can improve symptoms. Patients 
who perceive that their symptoms are severe are more likely to consider treatment.  
What does this paper add to the literature?  
This study found that rectal irrigation is an acceptable method of treatment for the symptomatic 
relief of low anterior resection syndrome (LARS). Control of LARS symptoms with frequent use of 
rectal irrigation can improve quality of life and it should be offered as a treatment option. 
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Introduction  
Recent advances in the management of colorectal cancer have improved patient survival. However, 
with improved survival, there is increasing recognition of long term functional side effects following 
rectal cancer treatment. Anterior resection with sphincter preservation is currently the standard of 
care for the management of low to mid rectal cancers [1]. Between 60-90% of patients following an 
anterior resection report severe post-operative bowel dysfunction in the first 12 months, with 1 in 4 
patients experiencing effects for a longer period. Symptoms include urgency, frequency, faecal 
incontinence and flatulence [2] and it is often termed Low Anterior Resection Syndrome (LARS) [3-6]. 
For these patients who have undergone curative oncological resection, it is essential that effective 
treatment strategies are identified in order to ensure that patients can experience a good quality of 
life (QoL). 
 
Patients with LARS often rely on strategies such as the use of pads, self-medication with laxatives 
and changes to diet in an attempt to control symptoms [7,8]. Biofeedback can be used to help 
patient with improving evacuation or incontinence and is often the first line treatment option. Rectal 
irrigation could also offer a potential solution for the management of LARS symptoms.  A survey of 
colorectal surgeons across the USA and Spain suggested that less than one third of surgeons would 
consider offering rectal irrigation as a form of treatment for LARS and very few would offer it as a 
first line treatment [8]. 
 
The procedure involves the use of water to irrigate the recto-sigmoid colon to initiate evacuation, 
thereby reducing the risk of faecal incontinence. Rectal irrigation systems such as Peristeen© 
(Coloplast, UK) involve a disposable rectal catheter and a control unit consisting of a pump and 
water bag. Once the catheter is inserted into the anus, 500-1000ml of water can be manually 
pumped into the bowel using the control unit and once the catheter is removed, faecal evacuation 
occurs. Although rectal irrigation does not resolve the aetiology behind LARS, it can be used to 
control symptoms including the timing of defaecation which may be of benefit to the patient [9]. 
Empirical evidence suggests rectal irrigation can improve QoL and provide symptomatic relief in 
those with faecal incontinence, chronic constipation [11] and LARS following anterior resection [11-
13].  Although QoL and functional outcomes improved following the use of rectal irrigation, the 
evidence is restricted to quantitative studies using validated questionnaires to assess outcomes. The 
acceptability of rectal irrigation as a treatment option, the subjective experience of the patient using 
rectal irrigation and how this treatment may impact QoL have not been fully explored.  
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To our knowledge, no qualitative study has explored the acceptability and impact of rectal irrigation 
in patients with LARS. The present study aimed to assess the acceptability of rectal irrigation in 
patients who accept or decline treatment, including a qualitative exploration of the factors 
influencing their decision, impact of treatment in terms of QoL, faecal incontinence and the patient 
reported experience. 
 
Method 
All study materials and the study procedure was developed with lay input. The lay member of the 
research team was asked to provide feedback on readability of information sheets and provide input 
on how to minimise patient workload and improve study design. 
 
Patients were identified through a prospective database held in Cardiff and Vale University Health 
Board’s colorectal department. All patients undergoing an anterior resection for rectal cancer 
(between January 2009 and January 2014), who were aged 18 years or older and had bowel 
continuity restoration for a minimum of 12 weeks were eligible for the study (Figure 1). Patients 
were excluded if they were unable to provide informed consent, had previously used rectal irrigation 
or were not physically capable of performing rectal irrigation treatment at home.  
 
Local ethical approval was obtained for this study (NISCHR 15/WA/0089). Eligible participants were 
sent an invitation letter by post with a brief outline of the study and a LARS-score questionnaire for 
completion [14,15]. Non-responders were contacted by telephone. Participants with LARS syndrome 
defined as a score of >20 on the LARS-score questionnaire were invited to attend outpatient clinic 
for assessment where they were screened for contraindications precluding rectal irrigation (Figure 
1). Severity of LARS symptoms were graded from mild (score 21-29) to major (score 30-42) [14,15]. 
Participants were invited to an outpatient clinic six weeks after the initial appointment to discuss the 
study and watch a demonstration of the rectal irrigation system (Peristeen©). During this 
appointment those who agreed to take part in the study, regardless of whether they accept 
(treatment group) or decline treatment (comparator group), were asked to complete a consent form 
for the study. Those who consented to the study were asked to complete questionnaires to assess 
faecal incontinence using the St Mark’s questionnaire [16]. All participants were invited to take part 
in a qualitative interview at the point of treatment acceptance or refusal (Figure 1).  
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Participants in the treatment group were reviewed via telephone by the clinic nurses one and two 
months after the initial appointment and in outpatient clinic after three and six months, in line with 
existing pathways for patients who start rectal irrigation within the Trust. Participants were provided 
with contact details for the clinic nurses should they require additional support in between follow up 
telephone calls and appointments. All participants (treatment and comparator groups) were asked 
to complete the LARS and faecal incontinence questionnaires at six month follow up. Participants in 
the treatment group were invited to take part in a qualitative interview at six months or at the point 
of drop out (Figure 1).  
 
We aimed to interview up to eight participants per group (treatment- completed group; treatment- 
dropped out group; comparator group) until data saturation (no new themes emerging). Twelve 
participants who accepted treatment were interviewed. One participant did not complete treatment 
but declined to participate further in the study and refused a follow up interview. Therefore we were 
unable to conduct any incomplete treatment- interviews. The six participants who refused treatment 
were approached for an interview and five agreed. 
 
Semi-structured telephone interviews were conducted with a trained qualitative researcher (GM; a 
health psychology PhD student), supported by a topic guide. Topics for the initial interview included 
the nature and impact of LARS symptoms on QoL, treatment acceptability and factors influencing 
the decision to accept or decline rectal irrigation. Topics under discussion during the follow up 
interview (treatment group only) included usability of rectal irrigation, acceptability and impact of 
rectal irrigation on LARS symptoms and QoL. Interviews were audio-recorded with permission and 
transcribed verbatim.  
  
Data analysis 
 
The study was not powered to explore statistical differences between groups therefore no statistical 
analysis of the quantitative data was performed. Qualitative data were analysed thematically. 
Themes were generated from the data and coded using NVivo 10. Four transcripts were double 
coded by another member of the research team (ZD) to reduce subjectivity and potential bias with 
interpretation of findings. All discrepancies were resolved through discussion. 
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Results 
Of the 85 eligible participants (male, n=57; female, n=28), twenty-one participants (male, n=18; 
female, n=3) consented to participate in the study (25% response rate) (Table 1).  
Fifteen participants accepted rectal irrigation (treatment group) and six declined treatment 
(comparator group). Demographics, baseline LARS and faecal incontinence scores plus six month 
faecal incontinence scores were similar between treatment and comparator groups (Table 1).  
Of the 15 participants who accepted treatment, 12 were interviewed (80%) and five of the six (83%) 
participants who declined treatment were interviewed. A summary of the qualitative findings under 
key themes are reported, with example quotations is presented in Table 2.  
Living with LARS  
Symptoms 
Participants reported symptoms of urgency, frequency (up to 20 times per day), incomplete 
evacuation, incontinence, constipation (followed by symptoms of urgency and frequency), and 
flatulence. Urgency, frequency and incontinence were considered most detrimental to daily life. 
Some participants and their spouses became in effect housebound, severely affecting QoL. For 
participants with symptoms of urgency and frequency throughout the night, lack of sleep and 
broken sleep impaired functioning during the day, affecting QoL. 
Changes to daily life 
Participants often avoided social events, long journeys, playing or watching sport, and everyday 
outings such as food shopping where they could not be sure toilets were readily accessible. Such 
activities were avoided through fear of having an accident or embarrassment associated with visiting 
the lavatory multiple times during a social event.  
Strategies to control symptoms and the need for planning 
All participants reported attempts to control symptoms through medication such as laxatives or diet 
manipulation. If participants attended social events or other activities, meticulous planning was 
involved in the days leading up to the event to ensure symptoms were controlled using diet and 
medication, and preparations were made to ensure they knew of the location of all available toilets 
in the vicinity.  
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Impact of LARS on work 
Participants in current employment reported difficulties with managing symptoms during working 
hours. Participants were required to discuss their previous diagnosis of cancer and symptoms with 
colleagues, which was embarrassing. For example, one participant worked in transport and was 
required to divulge personal information about cancer diagnosis and bowel function with students 
on their first meeting in order to pre-warn of the urgency to stop for a toilet if required.  
Disclosure of symptoms  
Although LARS severely impaired QoL, participants were grateful and thankful to have survived a 
diagnosis of cancer and there was a perception that they should not complain about their LARS 
symptoms. It could be postulated that this could deter disclosure of symptoms or downplay the 
impact of symptoms on daily life to family and clinicians during a consultation.  
Explanation of rectal irrigation as a treatment option 
The booklet outlining the rectal irrigation procedure and the demonstration provided during clinic 
was considered by participants as informative and helpful for facilitating the decision to accept or 
decline treatment. The section in the booklet which contained case studies of people with LARS 
symptoms who were using rectal irrigation and reported benefit motivated participants to try rectal 
irrigation. All participants expressed concern about the procedure, where worries tended to cluster 
around the potential for bowel perforation or pain associated with the procedure. However, 
concerns were often resolved during the outpatient clinic appointment with the nurse, thus 
reinforcing the importance of knowledge and familiarity with the procedure. 
Refusal of rectal irrigation  
Nature of symptoms and logistical considerations 
Participants who felt they had less severe or improving symptoms, controlled by diet and 
medication, declined treatment.  The logistics and practicalities of performing the procedure were 
taken into account when considering rectal irrigation. Those with one toilet in the family home or 
problems with integrating the procedure into their working day influenced the decision to decline 
treatment, especially when symptoms were manageable or improving. However, all participants 
would consider rectal irrigation in the future should LARS symptoms worsen. In the months 
following participation in the study, some participants who initially refused treatment have been in 
contact the clinic nurses to request to try rectal irrigation.  
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The procedure 
For two male participants the concept of daily self-catheterisation was distressing and therefore 
they refused the option of irrigation. 
Accept rectal irrigation as a treatment option 
Nature of symptoms 
Symptoms were reported as more severe for participants who accepted than declined treatment, 
although this was not necessarily reflected in their LARS questionnaire severity score. Those who 
accepted treatment were unable to control symptoms by diet or medication and were often 
housebound. Although many were apprehensive about the treatment procedure, LARS symptoms 
were so detrimental on QoL that they were ‘willing to try anything’ with the potential to resolve and 
manage symptoms. For these participants, the potential benefits of treatment and the desire for life 
to return to ‘normality’ outweighed any potential side effects.  
Using rectal irrigation 
Initially, participants experienced problems with using the equipment properly often resulting in trial 
and error with water quantities and the depth of insertion of the catheter into the anus. However, 
once used a few times, participants gained confidence and could use the equipment effectively and 
efficiently. Only one patient required additional telephone support from the nurse outside of their 
allocated outpatient appointment. 
Most participants used rectal irrigation daily, and the time required ranged from 30 to 45 minutes. 
Taking into account the length of time required throughout the day and the unpredictability of 
bowel motions with LARS prior to using rectal irrigation, 30-45 minutes was considered by 
participants as a benefit, particularly when they had complete control over the time of defaecation.  
Impact of rectal irrigation on QoL 
For participants who completed treatment, rectal irrigation was often described as ‘life changing’ 
and all participants would highly recommend it to anyone with LARS. Participants reported re-
gaining complete control over their bowel movements and were confident in the ability to pursue 
the activities which they had previously avoided such as swimming, socialising and long trips, 
thereby improving QoL. The benefits extended to spouses who had previously forfeited social 
activities to because of their partner’s symptoms. Participants used phrases such as ‘I have my life 
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back’, as a consequence of using rectal irrigation as they were able to carry on with life as it was 
before surgery.  
Discussion 
This was the first qualitative study to explore acceptability of rectal irrigation for patients with LARS 
following anterior resection for rectal cancer. Participants were initially apprehensive of rectal 
irrigation, although concerns were often resolved through discussion with the nurse. Treatment was 
acceptable for the majority of participants; however, the procedure of self-catheterisation deterred 
participation in a minority of participants. Other influences on treatment acceptance were perceived 
symptom severity: those with manageable and improving symptoms declined treatment; however, 
those with severe and poorly controlled symptoms accepted treatment. Rectal irrigation was 
reported to lead to greater perceived control over symptoms and consequently improved QoL. 
Functional outcomes (severity of LARS and faecal incontinence) that participants reported during 
interviews did not necessarily reflect those of the LARS questionnaire performed at baseline. All 
participants that consented to be interviewed but declined irrigation (n=5) reported severe LARS 
scores on the questionnaire but during the interview perceived that their symptoms were not as 
severe or were improving.  
Our findings are in line with previous survey studies reporting a positive influence of rectal irrigation 
on QoL [10-13]. Through qualitative methods we were able to provide insight into the patient 
reported experience of using rectal irrigation and how regaining control of symptoms thorough the 
use of rectal irrigation could improve their QoL.  
We found evidence that patients may experience feelings of guilt and a perception that they should 
be grateful to survive a diagnosis of bowel cancer. Consequently, patients may withhold full 
disclosure of symptoms to their clinician. It is likely that previous studies highlighting the disparity 
between patient and clinician views on the impact of LARS on QoL [8,17] could be explained by 
patients minimising or opting not to disclose symptoms to their clinical team. It is therefore 
imperative that patients are aware of the symptoms of LARS preoperatively and that treatment 
strategies are available, to facilitate recognition of LARS symptoms.  
Clinicians should be aware that patients may not disclose symptoms during a consultation unless 
prompted. Therefore, regular assessment of bowel function to screen for LARS should be made as 
symptoms may vary over time. LARS screening can be done as part of the Holistic Needs Assessment 
which should be performed in line with NHS England Cancer Task Force guidelines. Regular LARS 
screening should include questionnaires to assess bowel function such as the LARS score although 
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these may not accurately reflect the patient perception of symptom severity. Therefore, most 
importantly, it is the patient’s own reported experience of severity of symptoms which will 
determine the need for intervention.  
One recent study suggested that the LARS score can under or overestimate symptoms and therefore 
should be used in conjunction with other scoring tools and assessments [18]. We recommend that 
questionnaires such as the LARS score should be used during bowel function assessments as an 
adjunct to prompt and guide discussion around severity of symptoms. In addition, information 
should be made available to increase clinician awareness of treatment options available to patients 
with LARS such as rectal irrigation.  
There were some limitations of this study. First, as with all qualitative research the sample may not 
be representative of a larger group, therefore care has to be taken when attempting generalisations 
from these data. For instance, although female gender is a risk factor for major LARS and most 
previous studies have explored the use of rectal irrigation in a pelvic floor setting with females, our 
sample was biased towards male respondents (over 80%). Due to the low numbers of female 
patients interviewed  we were unable to explore the reasons for a higher male response in our 
sample. Reasons for refusal of rectal irrigation for the female participants in this study (n=2) were 
mainly centred on perceptions that symptoms were improving. In male participants, either the 
procedure of self-catheterisation or improving symptoms was a deterrent to treatment acceptance. 
Therefore, we can hypothesise that female response was lower because they felt symptoms were 
being managed, although further research is required to explore this in more depth. In addition, 25% 
of those invited to participate in the study consented to take part. Although a proportion of these 
patients had died or reported LARS scores of <20, 31 participants did not return the questionnaire or 
refused to participate in the study. We were unable to collect data for reasons for refusal, although 
we can postulate, based on our interview findings, that patients may refuse to take part because 
symptoms did not affect their perceived QoL. Second, this was a qualitative project and for which 
there was no intention to undertake statistical analysis on the quantitative data as the sample was 
not powered to explore statistical associations. Finally, we were unable to collect data on reasons for 
drop out of treatment. The only participant who dropped out of the treatment group also withdrew 
from the study and could not therefore be interviewed. Future trials should explore patient 
characteristics for those who accept or decline treatment, including barriers and motivators to 
participation.  
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Conclusion 
Clinicians should consider offering rectal irrigation as a treatment option for patients presenting with 
bowel dysfunction following anterior resection, particularly in patients who perceive themselves as 
having severe symptoms. Functional scores and other tools alone may not reflect patients’ 
perception of symptom severity. Transanal irrigation has the potential to improve symptoms of LARS 
and QoL. 
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Table 1.  
 Treatment group  
(Peristeen use) 
(n=15) 
Comparator group 
(usual care) 
(n=6) 
Gender 
   Male, n (%) 
   Female, n (%) 
 
14 (93%) 
1 (7%) 
 
4 (67%) 
2 (33%) 
Age  
   Mean (range) 
 
65 (36-79) 
 
60 (46-71) 
Severity of symptoms 
  Major LARS (LARS score >30), n (%) 
  Minor LARS (LARS score 21-29),  n (%) 
 
13 (87%) 
2 (13%) 
 
6 (100%) 
0 
Surgical intervention 
  Anterior resection 
  Anterior resection and defunctioning stoma 
 
12 (80%) 
3 (20%) 
 
3 (50%) 
3 (50%) 
Disease TNM staging 
  T3 disease, n (%) 
  T2 Disease, n (%) 
  T1 disease, n (%) 
  No residual disease (post TEMS), n (%) 
 
7 (47%) 
4 (27%) 
3 (20%) 
1 (8%) 
 
2 (33%) 
3 (50%) 
1 (17%) 
0 
Neo-Adjuvant Chemotherapy 
Yes, n (%) 
No, n (%) 
 
6 (40%) 
9 (60%) 
 
1 (17%) 
5 (83%) 
Radiotherapy 
Yes, n (%) 
No, n (%) 
 
5 (33%) 
10 (67%) 
 
1 (17%) 
5 (83%) 
Height of anastomosis (with radiotherapy) 
Mean, cm (range)  
 
9.25 (7-12) 
 
8.5  (4-15) 
Smoking status 
Current smoker, n (%) 
Not current smoker, n (%) 
 
1 (7%) 
13 (93%) 
 
2 (33%) 
4 (67%) 
Loperamide use 
Regular use of Loperamide, n (%) 
 
4 (27%) 
 
4 (67%) 
16 
 
No regular use of Loperamide, n(%) 11 (73%) 2 (33%) 
Spinal conditions 
Chronic spinal conditions, n (%) 
No spinal conditions, n (%) 
 
3 (20%) 
12 (80%) 
 
1 (17%) 
5 (83%) 
LARS score 
Baseline, mean (range) 
Six month follow up, mean (range) 
 
35.93 (21-42) 
17.73 (0-41) 
 
34.17 (32-37) 
32.35 (26-37) 
St Marks score 
Baseline, mean (range) 
Six month follow up, mean (range) 
 
9.73 (2-15) 
3.20 (0-9) 
 
9.33 (4-13) 
5.40 (0-9) 
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Table 2. Example quotations 
Theme Example quotation 
Living with LARS “Unfortunately [the reversal] has left me a situation where I go [to the toilet] 
in the evening...anything up to 15-20 times” (Male, treatment group- 
completed) 
“If I go out for the evening...I have to find where the toilet is and then I need to 
go 4 or 5 times in the night.  So it really is sort’ve something to do with our 
social life but also just not very nice...yes it does affect how much you do” 
(Male, treatment group- completed) 
Explanation of 
rectal irrigation 
as a treatment 
option 
“The nurse I dealt with, she was brilliant, really, really good.  She explained it 
all, and then she went through what would be involved she was fantastic” 
(Male, treatment group- completed) 
“I was reading [the booklet] through the other night and it was saying a lot of 
people it would do them good like...that’s why I took [rectal irrigation] up” 
(Male, treatment group- completed) 
Refusal of rectal 
irrigation 
“I think I am actually, I think I’m controlling it...it’s a lot better than when I had 
the bag and it’s a lot better than when I had the reversal” (Male, comparator 
group) 
“At the moment I declined [rectal irrigation] because I seem to be managing 
okay” (Female, comparator group) 
“It comes down to the basic point to having to put a catheter up your rectum 
everyday and fill yourself with water doesn’t appeal at all.  I think my symptoms 
would have to be quite severe for me to say yes I’d be prepared to do that” 
(Male, comparator group)” 
Accept rectal 
irrigation as a 
treatment 
option 
“You understand what the main aspect of it is and I must admit at one point I 
thought ‘I’ve got to do this’, but you balance that against what could be the 
benefits and so I thought yep I’m gonna go for it and I’m gonna do it because it 
is the opportunity to make your life better” (Male, treatment group- 
completed) 
18 
 
“I thought I’d give it a go because I tried everything else and you know, so I just 
wanna try this and give it a go innit?” (Male, treatment group- completed) 
Using rectal 
irrigation 
“I was a bit nervous...to put [the catheter] up the back passage, but, after 2 or 
3 days it was excellent you knew what to do then.” (Male, treatment group- 
completed)  
Impact of 
treatment on 
quality of life 
“It’s excellent, absolutely excellent it is.  I can’t do without it tell the 
truth...otherwise I can’t go out because you know I’m looking for the toilet all 
the time” (Male, treatment group- completed) 
“I would say the phrase that probably sums [rectal irrigation] up best for me is 
life changing. Because my life compared to before [rectal irrigation] has 
changed vastly...it really made a major difference to me and my wife” (Male, 
treatment group- completed) 
“It’s changed my whole life...my lifestyle all that kind’ve stuff...I’m not rushing 
off to the toilet all the time so a lot better in myself” (Male, treatment group- 
completed) 
 
  
19 
 
Figure 1. Flow chart of participant recruitment and study procedure 
 
